SG Americas Securities LLC Has $732,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

SG Americas Securities LLC decreased its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 86.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 31,087 shares of the company’s stock after selling 192,479 shares during the period. SG Americas Securities LLC’s holdings in ARK Genomic Revolution ETF were worth $732,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of ARKG. Northwestern Mutual Wealth Management Co. grew its position in ARK Genomic Revolution ETF by 2.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after buying an additional 3,341 shares during the period. Sanctuary Advisors LLC bought a new position in ARK Genomic Revolution ETF during the second quarter valued at about $222,000. Dynamic Advisor Solutions LLC grew its position in ARK Genomic Revolution ETF by 7.8% during the third quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock valued at $348,000 after buying an additional 989 shares during the period. Brown Miller Wealth Management LLC grew its position in ARK Genomic Revolution ETF by 5.5% during the third quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock valued at $460,000 after buying an additional 933 shares during the period. Finally, Elmwood Wealth Management Inc. grew its position in ARK Genomic Revolution ETF by 39.7% during the third quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock valued at $1,479,000 after buying an additional 16,412 shares during the period.

ARK Genomic Revolution ETF Price Performance

ARKG opened at $26.26 on Thursday. The firm’s fifty day moving average is $25.10 and its 200-day moving average is $25.18.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.